These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15161930)

  • 61. Tamoxifen and raloxifene differ in their functional interactions with aspartate 351 of estrogen receptor alpha.
    Dayan G; Lupien M; Auger A; Anghel SI; Rocha W; Croisetière S; Katzenellenbogen JA; Mader S
    Mol Pharmacol; 2006 Aug; 70(2):579-88. PubMed ID: 16679488
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interaction of tetrahydrocrysene ketone with estrogen receptors alpha and beta indicates conformational differences in the receptor subtypes.
    Tyulmenkov VV; Klinge CM
    Arch Biochem Biophys; 2000 Sep; 381(1):135-42. PubMed ID: 11019829
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres.
    Iannone MA; Consler TG; Pearce KH; Stimmel JB; Parks DJ; Gray JG
    Cytometry; 2001 Aug; 44(4):326-37. PubMed ID: 11500849
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Distinction of the binding modes for human nuclear receptor ERRgamma between bisphenol A and 4-hydroxytamoxifen.
    Liu X; Matsushima A; Okada H; Shimohigashi Y
    J Biochem; 2010 Aug; 148(2):247-54. PubMed ID: 20542892
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Crystal structure of a mutant hERalpha ligand-binding domain reveals key structural features for the mechanism of partial agonism.
    Gangloff M; Ruff M; Eiler S; Duclaud S; Wurtz JM; Moras D
    J Biol Chem; 2001 May; 276(18):15059-65. PubMed ID: 11278577
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A triple mutant of the Drosophila ERR confers ligand-induced suppression of activity.
    Ostberg T; Jacobsson M; Attersand A; Mata de Urquiza A; Jendeberg L
    Biochemistry; 2003 Jun; 42(21):6427-35. PubMed ID: 12767224
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Estrogen receptor-related receptor gamma has an exceptionally broad specificity of DNA sequence recognition.
    Razzaque MA; Masuda N; Maeda Y; Endo Y; Tsukamoto T; Osumi T
    Gene; 2004 Oct; 340(2):275-82. PubMed ID: 15475169
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The unusual binding properties of the third distinct teleost estrogen receptor subtype ERbetaa are accompanied by highly conserved amino acid changes in the ligand binding domain.
    Hawkins MB; Thomas P
    Endocrinology; 2004 Jun; 145(6):2968-77. PubMed ID: 15001543
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Interactions of synthetic estrogens with human estrogen receptors.
    Nikov GN; Eshete M; Rajnarayanan RV; Alworth WL
    J Endocrinol; 2001 Jul; 170(1):137-45. PubMed ID: 11431146
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Structural insights into selective agonist actions of tamoxifen on human estrogen receptor alpha.
    Chakraborty S; Biswas PK
    J Mol Model; 2014 Aug; 20(8):2338. PubMed ID: 25060147
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Implications of the binding of tamoxifen to the coactivator recognition site of the estrogen receptor.
    Kojetin DJ; Burris TP; Jensen EV; Khan SA
    Endocr Relat Cancer; 2008 Dec; 15(4):851-70. PubMed ID: 18755852
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Positive and negative discrimination of estrogen receptor agonists and antagonists using site-specific DNA recombinase fusion proteins.
    Logie C; Nichols M; Myles K; Funder JW; Stewart AF
    Mol Endocrinol; 1998 Aug; 12(8):1120-32. PubMed ID: 9717838
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The F domain of estrogen receptor α is involved in species-specific, tamoxifen-mediated transactivation.
    Arao Y; Korach KS
    J Biol Chem; 2018 Jun; 293(22):8495-8507. PubMed ID: 29632071
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Synthesis and biological evaluation of novel 4-hydroxytamoxifen analogs as estrogen-related receptor gamma inverse agonists.
    Kim J; Chin J; Im CY; Yoo EK; Woo S; Hwang HJ; Cho JH; Seo KA; Song J; Hwang H; Kim KH; Kim ND; Yoon SK; Jeon JH; Yoon SY; Jeon YH; Choi HS; Lee IK; Kim SH; Cho SJ
    Eur J Med Chem; 2016 Sep; 120():338-52. PubMed ID: 27236015
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Distinct effects on the conformation of estrogen receptor alpha and beta by both the antiestrogens ICI 164,384 and ICI 182,780 leading to opposite effects on receptor stability.
    Van Den Bemd GJ; Kuiper GG; Pols HA; Van Leeuwen JP
    Biochem Biophys Res Commun; 1999 Jul; 261(1):1-5. PubMed ID: 10405313
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
    Attardi B; Happe HK
    Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Molecular modelling of the human estrogen receptor and ligand interactions based on site-directed mutagenesis and amino acid sequence homology.
    Lewis DF; Parker MG; King RJ
    J Steroid Biochem Mol Biol; 1995 Jan; 52(1):55-65. PubMed ID: 7857874
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens.
    Hall JM; McDonnell DP
    Endocrinology; 1999 Dec; 140(12):5566-78. PubMed ID: 10579320
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Differential inhibition of estrogen and antiestrogen binding to the estrogen receptor by diethylpyrocarbonate.
    Borgna JL; Scali J
    J Steroid Biochem; 1988 Oct; 31(4A):427-36. PubMed ID: 3050278
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells.
    Kim K; Thu N; Saville B; Safe S
    Mol Endocrinol; 2003 May; 17(5):804-17. PubMed ID: 12576490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.